Evidence map›Paper›PMID 40707687›Full record

ArticleScientific reports2025

Combined exposure to three heavy metals and the risk of age-related macular degeneration in the Korean population.

Soonsu Shin, Jae-Hong Ryoo

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Soonsu ShinDepartment of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Jae-Hong RyooDepartment of Occupational and Environmental Medicine, School of Medicine, Kyung Hee University, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea. armani131@khu.ac.kr.

Funding

Ministry of Health and Welfare, Ministry of Science and ICT, Ministry of Trade, Industry and Energy, and Korea Disease Control and Prevention Agency RS-2024-00509118
6 · The paper itself

Abstract

Toxicological and histological evidence suggests that heavy metals accumulate in the retina, implicating their potential role in the development of age-related macular degeneration (AMD). However, most prior epidemiologic studies have focused on individual metal exposures, overlooking possible joint effects. This study assessed the association between co-exposure to lead (Pb), mercury (Hg), and cadmium (Cd) and AMD risk among Korean adults using 2008-2012 Korea National Health and Nutrition Examination Survey data. A total of 4818 participants aged 40 years or older were included. Logistic regression models evaluated single-metal associations, while quantile g-computation and Bayesian kernel machine regression (BKMR) assessed mixture effects. Participants in the third quartile of Pb had significantly higher odds of AMD (adjusted OR: 1.76, 95% CI: 1.07-2.88) than those in the lowest quartile. Quantile g-computation showed that a one-quartile increase in the metal mixture was associated with elevated AMD risk (adjusted OR: 1.20, 95% CI: 1.02-1.41). BKMR confirmed that the heavy metal mixture increased the risk of AMD, with Pb being the primary contributor in smokers and Cd in non-smokers. Our findings indicate that co-exposure to heavy metals elevates AMD risk and that the predominant contributing metal may differ depending on smoking status.

Indexed as

Environmental ExposureMacular DegenerationMetals, HeavyAdultAgedCadmiumFemaleHumansLeadMaleMercuryMiddle AgedNutrition SurveysRepublic of KoreaRisk FactorsCadmiumLeadMercuryMetals, HeavyAge-related macular degenerationCadmiumHeavy metalLeadMercury

Identifiers

PMID40707687
PMCPMC12290029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.